ETON

MKT CAP:$834M

Eton Pharmaceuticals Inc

Market Cap

$834M

Healthcare·Drug Manufacturers - Specialty & Generic·🇺🇸 United States·NASDAQ

Healthcare·Drug·🇺🇸·NASDAQ

Stock Price

$29.95+$13.69 (+84.19%)

Jun 8, 2026

52W High $35.0052W Low $13.50

Company Details

Eton Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing treatments for rare diseases. Its commercial rare disease products include Increlex for the treatment of severe primary igf-1 deficiency; Alkind...

CEO

—

IPO Date

Nov 13, 2018

Website

www.etonpharma.com

Key Metrics TTM

Revenue

$87M

+79.9% YoY

Net Income

-$1M

EPS (Diluted)

Free Cash Flow

$15M

Revenue / Share

$2.76

Gross Margin

54.8%

Operating Margin

2.3%

Net Margin

-1.7%

FCF Margin

17.8%

P/S

9.6x

P/E

Earnings Reports

Q1 2026

May 14, 2026

$24M+40.4%

FY 2025

Mar 19, 2026

$80M+104.9%

Q4 2025

Mar 19, 2026

$21M+82.7%

Q3 2025

Nov 6, 2025

$22M+117.5%

Q2 2025

Aug 7, 2025

$19M+108.6%

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee